FASTBASE SOLUTIONS
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.9Mattributed |
|---|---|
| Latest round | grant, $2.6M, 2024-02-28attributed |
| Founded | unknown |
| Headquarters | Biotechnology / Diagnostics |
| Industry | biotechnology |
| Stage | unknown |
| Website | fastbase-solutions.com |
Fastbase Solutions (HAWK Biosystems) developed a platform to discover and quantify novel disease biomarkers, including its QF-Pro assay. It targets immuno-oncology researchers and clinicians stratifying patients for treatment. Its differentiator is high-precision prediction of which patients will respond to immunotherapy.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-02-28 | grant | $2.6M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.6M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $2.9M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | fastbase-solutions.com, read 2026-05-08 |
| Description | self-reported | fastbase-solutions.com, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.